Literature DB >> 15961047

Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease.

Serge A R B Rombouts1, Rutger Goekoop, Cornelis J Stam, Frederik Barkhof, Philip Scheltens.   

Abstract

Functional MRI (fMRI) in established Alzheimer's disease (AD) shows regionally altered blood oxygenation level dependent (BOLD) responses. Mild cognitive impairment (MCI) is thought to represent an intermediate state between health and early Alzheimer's disease. To study this probable early dementia stage pathology, we studied in detail the BOLD response in MCI during visual encoding. 28 MCI patients, 18 AD patients, and 41 healthy elderly controls performed a face encoding task during fMRI scanning. Data were analyzed using orthogonal regressors, each representing different phases of the BOLD response (from slow to fast). Using a mixed effects model, regressor x group interactions were analyzed applying P < 0.05, corrected. In occipital regions, MCI patients could be distinguished significantly better from controls and AD patients with a regressor of the early phase of the (fast) BOLD response than with the regressor of the late (slow) BOLD phase. Occipitally, the early phase BOLD response was significantly diminished in MCI patients compared to controls, and significantly increased when compared to AD. AD patients showed diminished early phase activation in widespread regions throughout the brain when compared to controls. There were no differences in the late (slow) phase of the BOLD response. This study stresses the importance of analyzing early phase BOLD responses and not only using one model of the BOLD response in neurodegenerative diseases. The increasing delay of the BOLD response from controls to MCI to AD may be consistent with the idea that MCI is a transitional state between healthy aging and dementia. Analyzing differences in different phases of the BOLD response introduces new opportunities to understand changes in regional brain dynamics in MCI and how well this may serve as an early marker of AD pathology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961047     DOI: 10.1016/j.neuroimage.2005.03.022

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  54 in total

1.  Age-related differences in prefrontal cortex activity during retrieval monitoring: testing the compensation and dysfunction accounts.

Authors:  Ian M McDonough; Jessica T Wong; David A Gallo
Journal:  Cereb Cortex       Date:  2012-04-17       Impact factor: 5.357

2.  Event-related functional magnetic resonance imaging changes during relational retrieval in normal aging and amnestic mild cognitive impairment.

Authors:  Kelly S Giovanello; Felipe De Brigard; Jaclyn Hennessey Ford; Daniel I Kaufer; James R Burke; Jeffrey N Browndyke; Kathleen A Welsh-Bohmer
Journal:  J Int Neuropsychol Soc       Date:  2012-05-24       Impact factor: 2.892

3.  fMRI responses to words repeated in a congruous semantic context are abnormal in mild Alzheimer's disease.

Authors:  John M Olichney; Jason R Taylor; Shiaohui Chan; Jin-Chen Yang; Andrew Stringfellow; Dieter G Hillert; Amanda L Simmons; David P Salmon; Vicente Iragui-Madoz; Marta Kutas
Journal:  Neuropsychologia       Date:  2010-04-28       Impact factor: 3.139

4.  Whole brain analysis of T2* weighted baseline FMRI signal in dementia.

Authors:  Serge A R B Rombouts; Philip Scheltens; Joost P A Kuijer; Frederik Barkhof
Journal:  Hum Brain Mapp       Date:  2007-12       Impact factor: 5.038

Review 5.  Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging.

Authors:  Paul Bentley; Jon Driver; Raymond J Dolan
Journal:  Prog Neurobiol       Date:  2011-06-17       Impact factor: 11.685

Review 6.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

7.  Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's disease.

Authors:  Federica Agosta; Maria Assunta Rocca; Elisabetta Pagani; Martina Absinta; Giuseppe Magnani; Alessandra Marcone; Monica Falautano; Giancarlo Comi; Maria Luisa Gorno-Tempini; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2010-04       Impact factor: 5.038

Review 8.  Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies.

Authors:  Bradford C Dickerson; Reisa A Sperling
Journal:  Neuropsychologia       Date:  2007-12-08       Impact factor: 3.139

Review 9.  Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia.

Authors:  Cristina Carvalho; Sónia C Correia; Renato X Santos; Susana Cardoso; Paula I Moreira; Timothy A Clark; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

10.  The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory.

Authors:  Guofan Xu; Donald G McLaren; Michele L Ries; Michele E Fitzgerald; Barbara B Bendlin; Howard A Rowley; Mark A Sager; Craig Atwood; Sanjay Asthana; Sterling C Johnson
Journal:  Brain       Date:  2008-10-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.